Page last updated: 2024-08-21

butorphanol and Substance Withdrawal Syndrome

butorphanol has been researched along with Substance Withdrawal Syndrome in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (20.83)	18.7374
1990's	25 (52.08)	18.2507
2000's	12 (25.00)	29.6817
2010's	1 (2.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Howes, JF; Kotick, MP; Osgood, PF; Polazzi, JO; Razdan, RK; Schut, RN; Villarreal, JE	1
Bousquet, AR; Howes, JF; Kotick, MP; Polazzi, JO	1
Kotick, MP; Leland, DL	1
Grechko, OY; Litvinov, LA; Rashchenko, AI; Shtareva, DM; Spasov, AA	1
Jang, CG; Lee, KW; Lee, SY; Tian, YH; You, IJ	1
Amagasa, S; Igarashi, A; Sato, M; Yokoo, N	1
Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Tanaka, S; Tien, LT	1
Ho, IK; Rockhold, RW; Sinchaisuk, S	1
Jang, SY; Kim, Y; Oh, S	1
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT	2
Chudapongse, N; Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Sinchaisuk, S; Tanaka, S; Tien, LT	1
Jang, S; Kim, DS; Lim, HK; Oh, S	1
Fan, LW; Ho, IK; Liu-Chen, LY; Park, Y; Rockhold, RW; Tanaka, S; Tien, LT	1
Jang, CG; Lee, SY	1
Khazan, N; Steinfels, GF; Young, GA	1
Feng, Y; Ho, IK; Tokuyama, S; Wakabayashi, H	2
Feng, YZ; Ho, IK; Rockhold, RW; Zhang, T	1
Fukase, H; Fukuzaki, K; Koja, T; Lukas, SE; Nagata, R	1
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW	2
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M	1
Ho, IK; Hoskins, B; Jaw, SP	1
Ho, IK; Hoskins, B; Tokuyama, S; Wakabayashi, H	1
Ho, IK; Tokuyama, S	2
Feng, YZ; Ho, IK; Rockhold, RW; Tokuyama, S; Zhang, T; Zhu, H	1
Ho, IK; Hoshi, K; Ma, T	1
Ho, IK; Hoshi, K; Ma, T; Oh, S	1
Feng, Y; Ho, IK; Rockhold, RW	1
Feng, YZ; Ho, IK; Hoshi, K; Rockhold, RW; Tokuyama, S	1
Ho, IK; Rockhold, RW; Zhu, H	1
Feng, YZ; Ho, IK; Tokuyama, S; Wakabayashi, H; Zhu, H	1
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W	1
Ho, IK; Jang, CG; Rockhold, RW	1
Glatt, W	1
Ho, IK; Jang, C; Park, Y; Rockhold, RW	1
Greenwald, MK; Stitzer, ML	1
Chung, MW; Ho, IK; Kim, JI; Oh, S	1
Ho, IK; Horan, P	2
Bigelow, GE; Liebson, IA; Preston, KL	2
Naulty, JS; Weintraub, SJ	1
Brown, GR	1
Gmerek, DE; Woods, JH	1

Reviews

2 review(s) available for butorphanol and Substance Withdrawal Syndrome

Article	Year
Glutamate in opioid dependence. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1997, Volume: 17, Issue:4 Topics: Analgesics, Opioid; Animals; Butorphanol; Glutamic Acid; Locus Coeruleus; Microdialysis; Opioid-Related Disorders; Rats; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1997
The role of glutamate in physical dependence on opioids. Japanese journal of pharmacology, 1998, Volume: 76, Issue:1 Topics: Analgesics, Opioid; Animals; Butorphanol; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Neurons, Afferent; Opioid-Related Disorders; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1998

Trials

3 trial(s) available for butorphanol and Substance Withdrawal Syndrome

Article	Year
A new method for detoxifying opioid-dependent patients. Journal of substance abuse treatment, 1999, Volume: 17, Issue:3 Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Butorphanol; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome	1999
Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine. Drug and alcohol dependence, 1998, Dec-01, Volume: 53, Issue:1 Topics: Adult; Arousal; Brain; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Heroin Dependence; Humans; Hypnotics and Sedatives; Lorazepam; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome	1998
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:2 Topics: Adult; Butorphanol; Cognition; Double-Blind Method; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome	1988

Other Studies

43 other study(ies) available for butorphanol and Substance Withdrawal Syndrome

Article	Year
Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones. Journal of medicinal chemistry, 1980, Volume: 23, Issue:2 Topics: Acetates; Analgesics; Animals; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders	1980
Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Substance Withdrawal Syndrome	1981
Analgesic narcotic antagonists. 4. 7-Methyl-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones. Journal of medicinal chemistry, 1980, Volume: 23, Issue:12 Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Humans; Morphinans; Morphine Dependence; Narcotic Antagonists; Substance Withdrawal Syndrome	1980
STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE. Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:4 Topics: Analgesics; Analgesics, Opioid; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Drug Administration Schedule; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Morpholines; Naloxone; Narcotic Antagonists; Receptors, Opioid, mu; Substance Withdrawal Syndrome	2016
7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:8 Topics: Analgesics, Opioid; Animals; Brain; Butorphanol; Cell Count; Disease Models, Animal; Enzyme Inhibitors; Indazoles; Male; Narcotic Antagonists; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	2008
Acute withdrawal syndrome in a butorphanol-treated patient: an adverse combination of opioids. British journal of anaesthesia, 2008, Volume: 101, Issue:1 Topics: Acute Disease; Analgesics, Opioid; Butorphanol; Humans; Intraoperative Complications; Male; Middle Aged; Substance Withdrawal Syndrome	2008
Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Brain research bulletin, 2002, Volume: 58, Issue:2 Topics: Analgesics, Opioid; Animals; Binding Sites; Binding, Competitive; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Neurons; Opioid-Related Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Up-Regulation	2002
Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Pharmacology, biochemistry, and behavior, 2002, Volume: 74, Issue:1 Topics: Animals; Basal Ganglia; Butorphanol; Diffusion; Electric Stimulation; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome	2002
The bindings of [3H]muscimol and [3H]flunitrazapam are elevated in discrete brain regions of butorphanol-withdrawal rats. Neurochemical research, 2002, Volume: 27, Issue:9 Topics: Animals; Autoradiography; Brain; Butorphanol; Flunitrazepam; Immunohistochemistry; Male; Muscimol; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tritium	2002
Butorphanol dependence and withdrawal decrease hippocampal kappa 2-opioid receptor binding. Brain research, 2002, Dec-27, Volume: 958, Issue:2 Topics: Animals; Butorphanol; Hippocampus; Male; Opioid-Related Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	2002
Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol. Journal of neuroscience research, 2003, Jun-15, Volume: 72, Issue:6 Topics: Animals; Brain; Butorphanol; Dose-Response Relationship, Drug; Male; Naltrexone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders	2003
Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Neuroscience, 2003, Volume: 121, Issue:4 Topics: Animals; Behavior, Animal; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Up-Regulation	2003
Changes of the level of G protein alpha-subunit mRNA by tolerance to and withdrawal from butorphanol. Neurochemical research, 2003, Volume: 28, Issue:12 Topics: Animals; Base Sequence; Butorphanol; DNA Primers; Drug Tolerance; GTP-Binding Protein alpha Subunits; Male; Narcotics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance Withdrawal Syndrome	2003
Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression. Journal of neuroscience research, 2005, Oct-15, Volume: 82, Issue:2 Topics: Animals; Brain; Butorphanol; Disease Models, Animal; Down-Regulation; Gene Expression; Hippocampus; Injections, Intraventricular; Male; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome; Up-Regulation	2005
Increases in [(3)H]-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor binding and mRNA expression of AMPA-sensitive glutamate receptor A (GluR-A) subunits in rats withdrawn from butorphanol. Journal of toxicology and environmental health. Part A, 2005, Dec-10, Volume: 68, Issue:23-24 Topics: Analgesics, Opioid; Animals; Autoradiography; Brain; Butorphanol; Gene Expression Regulation; In Situ Hybridization; Injections, Intraventricular; Male; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Substance Withdrawal Syndrome; Tritium	2005
Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats. Pharmacology, biochemistry, and behavior, 1982, Volume: 16, Issue:1 Topics: Animals; Butorphanol; Female; Humans; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Pentazocine; Rats; Rats, Inbred Strains; Self Administration; Sleep, REM; Substance Withdrawal Syndrome	1982
Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. European journal of pharmacology, 1995, Jun-06, Volume: 279, Issue:1 Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Opioid-Related Disorders; Pons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochemical research, 1995, Volume: 20, Issue:6 Topics: Animals; Butorphanol; Cerebral Ventricles; Glutamic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Locus Coeruleus; Male; Microdialysis; Naloxone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys. Psychopharmacology, 1994, Volume: 116, Issue:4 Topics: Animals; Behavior, Animal; Buprenorphine; Butorphanol; Haloperidol; Imipramine; Macaca fascicularis; Male; Morphine; Morphine Dependence; Naloxone; Psychotropic Drugs; Substance Withdrawal Syndrome	1994
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol. European journal of pharmacology, 1994, May-12, Volume: 257, Issue:1-2 Topics: Animals; Butorphanol; Injections, Intraventricular; Male; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders	1994
Effects of nor-binaltorphimine on butorphanol dependence. European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3 Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor	1993
Butorphanol nasal spray for pain. The Medical letter on drugs and therapeutics, 1993, Nov-12, Volume: 35, Issue:909 Topics: Administration, Intranasal; Butorphanol; Drug Tolerance; Humans; Pain; Substance Withdrawal Syndrome	1993
Opioid antagonists and butorphanol dependence. Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:3 Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome	1993
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. European journal of pharmacology, 1995, Sep-15, Volume: 284, Issue:1-2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Behavior, Animal; Butorphanol; Cytosol; Enzyme Inhibitors; Isoquinolines; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Piperazines; Pons; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. Pharmacology, biochemistry, and behavior, 1996, Volume: 54, Issue:2 Topics: Animals; Biogenic Amines; Biogenic Monoamines; Brain Chemistry; Butorphanol; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats. Psychopharmacology, 1996, Volume: 125, Issue:2 Topics: Animals; Brain; Butorphanol; Calcium Channel Blockers; Cerebral Cortex; Corpus Striatum; Diltiazem; Dopamine; Male; Mesencephalon; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain research, 1996, May-25, Volume: 722, Issue:1-2 Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochemical research, 1996, Volume: 21, Issue:1 Topics: Animals; Butorphanol; Drug Evaluation, Preclinical; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Substance Withdrawal Syndrome	1996
Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus. European journal of pharmacology, 1996, Oct-31, Volume: 314, Issue:3 Topics: Analgesics; Analysis of Variance; Animals; Aspartic Acid; Benzeneacetamides; Butorphanol; Glutamic Acid; Injections, Intraventricular; Locus Coeruleus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1996
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain research, 1997, Apr-04, Volume: 753, Issue:1 Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders	1997
Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2 Topics: Animals; Butorphanol; Excitatory Amino Acids; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1997
The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Journal of biomedical science, 1998, Volume: 5, Issue:1 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Butorphanol; Glutamic Acid; Infusions, Parenteral; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Motor Activity; Naloxone; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders	1998
Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:4 Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine; Morphine Dependence; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord; Substance Withdrawal Syndrome	1998
Withdrawal from butorphanol dependence alters binding of [3H]phorbol dibutyrate to protein kinase C, but not of [3H]forskolin to adenylate cyclase. Brain research, 1999, Mar-13, Volume: 821, Issue:2 Topics: Adenylyl Cyclases; Animals; Autoradiography; Brain; Brain Chemistry; Butorphanol; Carcinogens; Colforsin; Male; Narcotic Antagonists; Opioid-Related Disorders; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tritium	1999
Autoradiographic study of NMDA-displaceable [3H]glutamate and [3H]MK-801 binding during butorphanol withdrawal in the rat brain. Brain research, 1999, Oct-23, Volume: 845, Issue:2 Topics: Animals; Autoradiography; Binding, Competitive; Brain Chemistry; Butorphanol; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Injections, Intraventricular; Male; N-Methylaspartate; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tritium	1999
Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and -withdrawing rats. Neurochemical research, 2000, Volume: 25, Issue:12 Topics: Animals; Autoradiography; Brain; Butorphanol; Dizocilpine Maleate; Drug Tolerance; In Situ Hybridization; Male; Narcotic Antagonists; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reference Values; RNA, Messenger; Substance Withdrawal Syndrome; Tissue Distribution	2000
Effects of beta-funaltrexamine on butorphanol dependence. Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:1 Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders	1992
The physical dependence liability of butorphanol: a comparative study with morphine. European journal of pharmacology, 1991, Oct-22, Volume: 203, Issue:3 Topics: Animals; Behavior, Animal; Body Weight; Butorphanol; Injections, Intraventricular; Male; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders	1991
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. NIDA research monograph, 1987, Volume: 76 Topics: Butorphanol; Heart Rate; Humans; Hydromorphone; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature; Substance Withdrawal Syndrome; Surveys and Questionnaires	1987
Butorphanol precipitates abstinence in morphine dependent rats. European journal of pharmacology, 1989, Nov-07, Volume: 170, Issue:3 Topics: Animals; Butorphanol; Dose-Response Relationship, Drug; Male; Morphinans; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome	1989
Acute abstinence syndrome after epidural injection of butorphanol. Anesthesia and analgesia, 1985, Volume: 64, Issue:4 Topics: Adult; Anesthesia, Epidural; Aspirin; Blood Pressure; Butorphanol; Caffeine; Cesarean Section; Codeine; Drug Combinations; Female; Humans; Morphinans; Nausea; Oxycodone; Phenacetin; Pregnancy; Reoperation; Substance Withdrawal Syndrome	1985
Stadol dependence: another case. JAMA, 1985, Aug-16, Volume: 254, Issue:7 Topics: Butorphanol; Humans; Male; Morphinans; Substance Withdrawal Syndrome; Substance-Related Disorders	1985
Substitution and primary dependence studies in animals. Drug and alcohol dependence, 1985, Volume: 14, Issue:3-4 Topics: Animals; Behavior, Animal; Benzomorphans; Buprenorphine; Butorphanol; Codeine; Discrimination, Psychological; Humans; Macaca mulatta; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Narcotic Antagonists; Pentazocine; Piperidines; Substance Withdrawal Syndrome	1985